Verily · 3 months ago
Software Engineer III, Enterprise Applications
Verily is a subsidiary of Alphabet focused on using data to improve health management and healthcare delivery. The Software Engineer III role involves developing systems for content management and localization in enterprise applications, directly impacting patient engagement and experience.
AnalyticsEnterprise SoftwareHealth CareInformation Technology
Responsibilities
Lead the development of complex technical solutions for enterprise web applications that configure and manage content for clinical trials and care programs
Collaborate with a team of software engineers, product managers, UX designers, and other cross-functional peers to deliver best-in-class software
Iterate and provide feedback on product requirements and mocks
Deliver software written in TypeScript/React and Go and deployed on GCP and enable third-party integrations that speed up implementation
Qualification
Required
3+ years of experience as a software engineer building web applications and backend systems
Demonstrated experience designing and delivering software in a collaborative environment with a cross-functional team
Bachelor's degree in Computer Science, related technical field, or equivalent practical experience
Preferred
Experience with TypeScript/React and/or Go
Deep understanding of design patterns for building robust, scalable, and maintainable applications
Ability to analyze complex problems and find effective solutions in a collaborative environment while seeking to improve team processes
Experience working in healthcare technology and/or familiarity with the HL7 FHIR standard
Benefits
Bonus
Benefits
Company
Verily
Verily is an Alphabet health tech company focused on research, care, and health financing to deliver on the promise of precision health. It is a sub-organization of Alphabet.
Funding
Current Stage
Late StageTotal Funding
$3.51BKey Investors
Michael J. Fox FoundationSwiss Re Corporate SolutionsSilver Lake
2025-04-30Grant· $14.7M
2022-09-29Secondary Market
2022-09-09Corporate Round· $1B
Recent News
2025-12-15
Dallas Innovates
2025-12-12
Company data provided by crunchbase